Latest Articles
ESPN+ price increase announced for Oct. 12: Here's how to save - Mashable
ESPN+ price increase announced for Oct. 12: Here's how to save Mashable
Published: Dec. 27, 2025, 3:30 a.m.
Low-Dose Dienogest Eases Endometriosis Pain in Trial - Bioengineer.org
Low-Dose Dienogest Eases Endometriosis Pain in Trial Bioengineer.org
Published: Dec. 25, 2025, 9:36 p.m.
Low-Dose Dienogest Eases Endometriosis Pain in Trial - BIOENGINEER.ORG
Low-Dose Dienogest Eases Endometriosis Pain in Trial BIOENGINEER.ORG
Published: Dec. 25, 2025, 9:36 p.m.
Danielle Collins teases broadcasting debut as she reveals 'egg freezing procedures' - Tennis365
Danielle Collins teases broadcasting debut as she reveals 'egg freezing procedures' Tennis365
Published: Dec. 23, 2025, 2:37 p.m.
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer - Targeted Oncology
Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer Targeted Oncology
Published: Dec. 23, 2025, 2:07 p.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer - Investing.com Nigeria
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer Investing.com Nigeria
Published: Dec. 23, 2025, 2:36 a.m.
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial - marketscreener.com
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial marketscreener.com
Published: Dec. 22, 2025, 11:40 a.m.
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer - Nasdaq
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer Nasdaq
Published: Dec. 22, 2025, 11:34 a.m.
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer - Nature
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer Nature
Published: Dec. 22, 2025, 10:55 a.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa
Published: Dec. 22, 2025, 8:15 a.m.
Link copied to clipboard!